References
- Shah M, Reed C. Complications of tuberculosis. Curr Opin Infect Dis 2014 Jul 15. [Epub ahead of print] doi: 10.1097/QCO.0000000000000090
- Fekih L, Boussoffara L, Fenniche S, et al. Neuropsychiatric side effects of antituberculosis agents. Rev Med Liege 2011;66:82–85
- Kass I, Mandel W, Cohen H, Dressler SH. Isoniazid as a cause of optic neuritis and atrophy. J Am Med Assoc 1957;164:1740–1743
- Keeping JA, Searle CW. Optic neuritis following isoniazid therapy. Lancet 1955;269:278. doi: 10.1016/S0140-6736(55)92696-9
- Holdiness MR. Neurological manifestations and toxicities of the antituberculosis drugs: a review. Med Toxicol 1987;2:33–51
- Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 2004;137:156–169
- Kirbas S, Turkyilmaz K, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 2013;33:62–65
- Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004;44:2793–2797
- Pueyo V, Ara JR, Almarcegui C, et al. Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis. Acta Ophthalmol 2010;88:748–752
- Türkyilmaz K, Oner V, Ozkasap S, et al. Peripapillary retinal nerve fiber layer thickness in children with iron deficiency anemia. Eur J Ophthalmol 2013;23:217–222
- Özkasap S, Türkyilmaz K, Dereci S, et al. Assessment of peripapillary retinal nerve fiber layer thickness in children with vitamin B12 deficiency. Childs Nerv Syst 2013;29:2281–2286
- Şahin A, Kürşat Cingü A, Kaya S, et al. The protective effects of caffeic acid phenethyl ester in isoniazid and ethambutol-induced ocular toxicity of rats. Cutan Ocul Toxicol 2013;32:228–233
- Kinoshita J, Iwata N, Maejima T, et al. Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy. Invest Ophthalmol Vis Sci 2012;53:7052–7062
- Kim YK, Hwang JM. Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy. J Ocul Pharmacol Ther 2009;25:531–535
- Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:895–897
- Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2005;243:410–416
- Polak BC, Leys M, van Lith GH. Blue-yellow colour vision changes as early symptoms of ethambutol oculotoxicity. Ophthalmologica 1985;191:223–226
- Gan NY, Teoh SC. Isoniazid-related bilateral choroidal effusions. Eye (Lond) 2010;24:1408–1409
- Van Stavern GP, Newman NJ. Optic neuropathies: an overview. Ophthalmol Clin North Am 2001;14:61–71
- Lalezary M, Medeiros FA, Weinreb RN, et al. Baseline optical coherence tomography predicts the development of glaucomatous change in glaucoma suspects. Am J Ophthalmol 2006;142:576–582
- Aouam K, Chaabane A, Loussaïef C, et al. Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patientmanagement. Med Mal Infect 2007;37:253–261
- Alasil T, Wang K, Yu F, et al. Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: a broken stick model. Am J Ophthalmol 2014;157:953–959